Module XVI - A Review of Antidotes

Wednesday May 5, 1999 - Question 12

Which of the following statements about bromocriptine is correct?

A. Bromocriptine is an ergot alkaloid with dopaminergic agonist effects.

B. Bromocriptine is a first-line agent for the treatment of severe neuroleptic malignant syndrome.

C. Bromocriptine should be administered as an intravenous bolus injection.

D. The initial dose of bromocriptine for NMS is 25 mg.

E. Bromocriptine can be stopped immediately when rigidity and fever resolve.
 
 

Discussion